MacBeath Gavin bought TCRX
October 1, 2026 · Form 4 insider transaction
MacBeath Gavin bought 1,000,000 shares of TScan Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,000,000
Price
$0.00
Total value
N/A
InsiderMacBeath Gavin
RoleOfficer, Director
SecurityVoting Common Stock
Transaction codeA: Grant or award
Transaction dateOctober 1, 2026
Filing dateOctober 2, 2026
Shares owned after1,049,767
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the restricted stock units ("RSUs") shall vest on September 30, 2028, with the remaining 75% of the RSUs vesting on the earlier of (i) reporting of completion of the pivotal trial of TSC-101, or (ii) September 30, 2030, subject to continued service with the Issuer through the applicable vesting dates and the terms of the Issuer's Amended and Restated 2021 Equity Incentive Plan and the applicable award agreement.